ABEO Abeona Therapeutics Inc

Price (delayed)

$1.43

Market cap

$141.27M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.91

Enterprise value

$137.4M

Sector: Healthcare
Industry: Biotechnology

Highlights

The company's gross profit rose by 43% QoQ
The revenue is up by 43% since the previous quarter
Abeona Therapeutics's debt has increased by 10% YoY but it has decreased by 2.8% QoQ
Abeona Therapeutics's equity has decreased by 43% YoY and by 11% QoQ
The company's quick ratio fell by 32% YoY and by 16% QoQ

Key stats

What are the main financial stats of ABEO
Market
Shares outstanding
98.79M
Market cap
$141.27M
Enterprise value
$137.4M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.37
Price to sales (P/S)
13.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.74
Earnings
Revenue
$10M
EBIT
-$80.12M
EBITDA
-$74.52M
Free cash flow
-$36.36M
Per share
EPS
-$0.91
Free cash flow per share
-$0.39
Book value per share
$1.04
Revenue per share
$0.11
TBVPS
$1.27
Balance sheet
Total assets
$151.2M
Total liabilities
$48.65M
Debt
$8.73M
Equity
$102.55M
Working capital
$55.78M
Liquidity
Debt to equity
0.09
Current ratio
2.33
Quick ratio
2.26
Net debt/EBITDA
0.05
Margins
EBITDA margin
-745.2%
Gross margin
100%
Net margin
-842.3%
Operating margin
-814.2%
Efficiency
Return on assets
-51.8%
Return on equity
-71.5%
Return on invested capital
-101.1%
Return on capital employed
-73.3%
Return on sales
-801.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ABEO stock price

How has the Abeona Therapeutics stock price performed over time
Intraday
-4.03%
1 week
-7.74%
1 month
-34.4%
1 year
-38.63%
YTD
-8.92%
QTD
-23.94%

Financial performance

How have Abeona Therapeutics's revenue and profit performed over time
Revenue
$10M
Gross profit
$10M
Operating income
-$81.42M
Net income
-$84.23M
Gross margin
100%
Net margin
-842.3%
The company's gross profit rose by 43% QoQ
The revenue is up by 43% since the previous quarter
ABEO's operating margin is up by 32% QoQ
Abeona Therapeutics's net margin has increased by 31% QoQ

Growth

What is Abeona Therapeutics's growth rate over time

Valuation

What is Abeona Therapeutics stock price valuation
P/E
N/A
P/B
1.37
P/S
13.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.74
ABEO's EPS is up by 40% year-on-year and by 12% since the previous quarter
The price to book (P/B) is 47% lower than the 5-year quarterly average of 2.7 but 2.1% higher than the last 4 quarters average of 1.4
Abeona Therapeutics's equity has decreased by 43% YoY and by 11% QoQ
ABEO's P/S is 95% below its 5-year quarterly average of 290.7
The revenue is up by 43% since the previous quarter

Efficiency

How efficient is Abeona Therapeutics business performance
The company's return on invested capital has surged by 70% YoY and by 26% QoQ
ABEO's ROS is up by 31% since the previous quarter
The company's return on assets fell by 17% YoY and by 10% QoQ
Abeona Therapeutics's return on equity has decreased by 17% YoY and by 15% QoQ

Dividends

What is ABEO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABEO.

Financial health

How did Abeona Therapeutics financials performed over time
The current ratio has declined by 32% year-on-year and by 14% since the previous quarter
The company's total assets fell by 32% YoY and by 5% QoQ
Abeona Therapeutics's debt is 91% lower than its equity
Abeona Therapeutics's debt to equity has surged by 125% YoY and by 13% QoQ
Abeona Therapeutics's equity has decreased by 43% YoY and by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.